Timers for Pedestrians Are a Requirement in the U.S. but Illegal for Drivers. (Getty). The countdown timer has been a feature of traffic lights in the United States since the 1990s, the first appearing in Hampton, Virginia, in 1996.
With GLYXAMBI, the dual inhibition of DPP-4 and SGLT2 â two proven targets in the treatment of type 2 diabetes â now provides U.S. physicians and patients with an option to simultaneously address multiple pathways to improve glycemic control.
Atezolizumab (trade name Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). It is currently in clinical trials as an immunotherapy for several types of solid tumors. It is under investigation by Genentech/Roche.